Latest stories on GRCE
Grace Therapeutics, Inc. (GRCE) files 8-K
SEC 8-K50 · neutralgeneral
Grace Therapeutics, Inc. (GRCE) files 8-K
SEC 8-K50 · neutralgeneral
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update | GRCE Stock News
StockTitan53 · neutralearnings
Grace Therapeutics VP of Clinical Operations Departs Role
TipRanks33 · bearishgeneral
Grace Therapeutics: Assessing The Path Forward For GTx-104
Seeking Alpha57 · neutralanalyst